Concepedia

Timothy L. Helms

TL

Statistics

Publications

4

Citations

632

H-Index

4

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of North Carolina at Chapel Hill

Massachusetts General Hospital

Timothy L. Helms is an author at The University of Texas MD Anderson Cancer Center specializing in molecular oncology, oncology, and cancer progression.

ORCID

Publications per year

2012–2020

4

Publications

4

Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma

Lawrence N. Kwong, James C. Costello, Huiyun Liu et al. · Nature Medicine · 2012 · 364 citations · Full text

, , +12

Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma

Lawrence N. Kwong, Genevieve M. Boland, Dennie T. Frederick et al. · Journal of Clinical Investigation · 2015 · 131 citations · Full text

, , +17

Efficacy of the combination of MEK and CDK4/6 inhibitors<i>in vitro</i>and<i>in vivo</i>in KRAS mutant colorectal cancer models

Michael S. Lee, Timothy L. Helms, Ningping Feng et al. · Oncotarget · 2016 · 126 citations · Full text

, , +15

<html>Efficacy of the combination of MEK and CDK4/6 inhibitors <i>in vitro</i> and <i>in vivo</i> in KRAS mutant colorectal cancer models</html>

Ji Yuan Wu, Garth Powis, Feng Tian et al. · UNC Libraries · 2020 · 11 citations · Full text

, , +15

1–4 of 4